Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes
Clinical trial NCT00508287 · COMPLETED
Trial details
- NCT number
- NCT00508287
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2007-11-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.